 |
Video: What is a Stock Split?
|
 |
Imprimis Pharmaceuticals is an ophthalmology-focused pharmaceutical company focused on the development, production and sale of medications. Co. operates its business through several subsidiaries: ImprimisRx, an ophthalmology focused compounding business; Park Compounding, a custom compounding business focused on patient specific orders; and Surface Pharmaceuticals, Inc., an ocular surface disease-focused 505(b)(2) specialty pharmaceutical subsidiary. According to our IMMY split history records, IMMY has had 2 splits. | |
 |

IMMY (IMMY) has 2 splits in our IMMY split history database. The first split for IMMY took place on February 08, 2013. This was a 1 for 5 reverse split, meaning for each 5 shares of IMMY owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. IMMY's second split took place on February 24, 2012. This was a 1 for 8 reverse split, meaning for each 8 shares of IMMY owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 25 share position following the split.
When a company such as IMMY conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IMMY split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IMMY shares, starting with a $10,000 purchase of IMMY, presented on a split-history-adjusted basis factoring in the complete IMMY split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/30/2015 |
|
End date: |
12/31/2018 |
|
Start price/share: |
$8.07 |
|
End price/share: |
$5.69 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-29.49% |
|
Average Annual Total Return: |
-9.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,051.66 |
|
Years: |
3.67 |
|
|
 |
Date |
Ratio |
02/08/2013 | 1 for 5 | 02/24/2012 | 1 for 8 |
|
 |